Development of an artificial intelligence software to detect interstitial pneumonias

Nishikiori, Hirotaka; Chiba, Hirofumi; Hirota, Kenichi; Suzuki, Tomohiro; Honda, Seiwa; Yama, Naoya; Ikeda, Kimiyuki; Mori, Yuki; Asai, Yuichiro; Koyama, Naomi; Kuronuma, Koji; Hatakenaka, Masamitsu; Takahashi, Hiroki

doi:10.1183/13993003.congress-2020.3716

Search citation statements

Order By: Relevance

Paper Sections

Select...

Interstitial Lung Disease1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, early ILD can be missed on chest X-ray examination alone. At ERS congress 2020, one study presented data from artificial intelligence (AI) software used to help physicians detect ILDs [32]. The area under the curve (AUC) of receiver operating characteristics (ROC) for the detection capability of AI was 0.979, with a sensitivity and specificity of 90% and 100% respectively, thus exceeding that of human physicians alone.…”

Section: Interstitial Lung Diseasementioning

confidence: 99%

ERS International Congress 2020: highlights from the Clinical Techniques, Imaging and Endoscopy assembly

et al. 2021

View full text Add to dashboard Cite

The European Respiratory Society (ERS) congress in the year 2020, a year dominated by the SARS-CoV-2 pandemic, was the first virtual congress that was ever planned with an innovative and interactive congress programme upfront. It was a large, novel platform for scientific discussion and presentations of cutting-edge innovative developments. This manuscript summarises a selection of the scientific highlights from the “Clinical techniques, imaging and endoscopy” Assembly 14. In addition to presentations on the important role of bronchoscopy, imaging and ultrasound techniques in the field of SARS-CoV-2 infection, novel diagnostic approaches and innovative therapeutic strategies in patients with lung cancer, interstitial lung disease, obstructive airway disorders and infectious diseases were also discussed.

show abstract

Section: Interstitial Lung Diseasementioning

confidence: 99%